ロード中...
Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis
INTRODUCTION: We sought to address whether there are clinical responses when patients who are failing gonadotropin-releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation therapy remains the backbone of treatment for disseminated prostate cancer and may be achieved w...
保存先:
| 出版年: | Can Urol Assoc J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Medical Association
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012296/ https://ncbi.nlm.nih.gov/pubmed/31348745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5996 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|